-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Description
AOD9604 (Advanced Obesity Drug 9604), particularly in the 2mg dosage form favored by bodybuilders, represents a fascinating intersection of metabolic science and physique enhancement. Unlike traditional anabolic steroids or even standard growth hormone (GH), AOD9604 targets fat metabolism with a unique mechanism derived from, but distinct from, human growth hormone. Its emergence in bodybuilding circles stems from its promise of potent fat loss without the significant side effects associated with many performance-enhancing drugs.

What is AOD9604?
AOD9604 is not simply a "piece" of HGH. It's a synthetically modified peptide fragment corresponding to amino acids 176-191 of the human growth hormone molecule (hGH 176-191). Crucially, its modification includes a tyrosine residue, enhancing its stability and metabolic activity. Developed initially by Metabolic Pharmaceuticals for obesity treatment (though never commercially approved as a drug), its mechanism is fundamentally different from full-length HGH:
●Mechanistic Divergence: While full HGH binds to its receptor triggering a cascade including IGF-1 release (responsible for growth and anabolic effects), AOD9604 primarily interacts with fat cell (adipocyte) receptors involved in lipolysis (fat breakdown) and inhibiting lipogenesis (fat creation). It mimics the fat-mobilizing region of HGH without significantly activating the GH receptor pathways linked to growth, blood sugar elevation, or IGF-1 surge. This is its key differentiator.
-

-
Features Defining AOD9604 for Bodybuilding
1.Targeted Lipolytic Action: Its primary feature is stimulating hormone-sensitive lipase (HSL), the enzyme crucial for breaking down stored triglycerides into free fatty acids (FFAs) for energy.
2.Anti-Lipogenic Effect: It helps suppress the activity of enzymes like fatty acid synthase (FAS), reducing the body's tendency to store new fat.
3.Minimal Anabolic/IGF-1 Activity: Crucially for bodybuilders concerned about organ growth or insulin resistance, AOD9604 exhibits negligible binding to the growth-promoting sites of the GH receptor. Its IGF-1 elevation is minimal and transient compared to full HGH.
4.Potential Metabolic Rate Modulation: Evidence suggests it may enhance metabolic rate independently of the thyroid axis, though the exact mechanism beyond fat cell targeting requires further elucidation.
5.Reduced Side Effect Profile: Due to its lack of significant GH/IGF-1 activity, it avoids common HGH side effects like carpal tunnel syndrome, joint pain, significant water retention, insulin resistance, and organomegaly at typical bodybuilding doses.
6.Preservation of Lean Mass: By facilitating fat as the primary fuel source during caloric deficits, it theoretically helps spare muscle glycogen and protein, aiding muscle retention during cuts.
Applications in the Bodybuilding Context
AOD9604 (2mg) finds its niche in specific phases of the bodybuilding calendar:
●Pre-Competition Cutting: Its primary use is accelerating stubborn fat loss (subcutaneous, visceral) during severe caloric restriction, helping achieve extreme leanness and definition without drastic muscle loss.
●Off-Season Fat Management: Used strategically to mitigate fat gain during muscle-building (bulking) phases, allowing for slightly higher caloric surplus while maintaining a leaner base.
●Metabolic "Reset": Some athletes use it post-diet or post-contest to help normalize metabolism impacted by prolonged dieting, though robust evidence for this is limited.
●Stubborn Fat Depot Targeting: Anecdotal reports suggest effectiveness on areas notoriously resistant to diet/exercise (lower abdomen, love handles, lower back).
-
Cycle Duration & Structure
●Typical Cycle Length: 6-12 weeks. Longer cycles (e.g., 12 weeks) are common due to its favorable safety profile.
●Onset of Effects: Noticeable fat loss effects typically manifest after 2-4 weeks of consistent use, building gradually.
●Cycling Rationale: Primarily to manage receptor sensitivity (though downregulation is less pronounced than with many drugs) and for cost management. A minimum break equal to the cycle length is often recommended (e.g., 8 weeks on, 8 weeks off).
●Stacking: Frequently combined with:
○GHRPs/GHRHs (e.g., CJC-1295 DAC/Ipamorelin): To potentially enhance overall fat loss and recovery via pulsatile GH release.
○Other Fat Loss Agents (e.g., SR9009): For synergistic metabolic effects (note: research chemicals carry significant unknowns).
○Base Hormones (Testosterone): Essential during severe cuts to prevent muscle catabolism. AOD9604 is not a testosterone replacement.
Benefits Over Traditional Compounds
●No Desensitization: Unlike beta-2 agonists (e.g., clenbuterol), AOD9604 does not downregulate receptors with prolonged use.
●Minimal Side Effects: Lacks the water retention, joint pain, or insulin resistance associated with hGH.
●Legal Status: Not classified as a controlled substance in many countries, making it accessible for research purposes.
●Non-Suppressive: Does not inhibit natural hormone production, eliminating the need for post-cycle therapy (PCT).
Dosage and Administration
●Effective Dose: 300–600 mcg per day, split into 1–2 subcutaneous injections.
●Timing: Preferentially administered in the morning or pre-workout to align with natural cortisol rhythms.
●Cycle Length: 8–12 weeks, with no required off-period due to its non-hormonal nature.
●Reconstitution: Mixed with bacteriostatic water; stable for 2–3 weeks when refrigerated.
Pharmacokinetics: Half-Life and Metabolism
●Half-Life: ~30 minutes, necessitating daily dosing for sustained effects.
●Metabolism: Degraded by peptidases in the bloodstream, with metabolites excreted renally.
●Bioavailability: 95% via injection; oral use is ineffective due to gastric degradation.
Conclusion
AOD9604 2mg/vial represents a fascinating chapter in the ongoing research into metabolic manipulation. It is a compound born from a logical scientific premise: isolating the beneficial fat-loss properties of HGH. Its theoretical features-targeted lipolysis, potential insulin sensitivity improvement, and absence of growth effects-make it a compelling subject for bodybuilding-related research.
However, its application exists firmly in a gray area of science. The disparity between promising mechanistic theories and mixed clinical trial results necessitates a highly cautious and skeptical approach. For the research community, it remains a peptide of significant interest for exploring the frontiers of fat metabolism and body recomposition. Its true potential and efficacy in a practical context continue to be a subject for further rigorous, ethical, and controlled scientific investigation.
-
Our Advantages
1.Quality:every item is strictly tested by our professional staff and get ISO certificate.
2.Price: much lower than our peers since we are factory. A discount would be given when you make a large order.
3.Delivery: We have adequate stock so we can make the delivery within 24 hours after payment.
4.Perfect Reshipping policy has been made to protect customers max bennefits and reduce the potentical losses.
5.Good after-sale service: always keeping track on the status of your parcel until delivered and trying our utmost to solve customers problems entounered
6.main products:Raw steroids,human growth hormone,Semi-finished oils,bodybuilding peptides,SARMs raws,Anabolic steroids -
-
Any needs, please contact me
Email: amyraws195@gmail.com
Whatsapp/Telegram: +852 56445864


-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hot Tags: peptides aod9604, China peptides aod9604 manufacturers, suppliers, factory, 2mg Vial Hexarelin Human Growth Peptides, 2mg Vial Human Growth Peptides MGF, Botox CAS 93384 43 1, CAS 121062 08 6, CAS 80449 31 6, CAS 946870 92 4












